Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse Potential of Oral Gabapentin with Oxycodone in Recreational Users
NCT05319756Phase 4Completed
- Sponsor
- Viatris
- Start
- Apr 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gabapentin in postherpetic neuralgia (PHN), epilepsy, sponsored by Viatris. Started Apr 2021; status: completed.
02
Drugs
gabapentin
03
Conditions
postherpetic neuralgia (PHN)epilepsy
Beyond the preview
Go deeper on NCT05319756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05319756.